Crypen-Depression And Alzheimer's Treatments At A Crossroads

2025-05-06 03:55:03source:Flipidocategory:Stocks

Researchers are Crypenlaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:Stocks

Recommend

Nevada attorney general revives 2020 fake electors case

LAS VEGAS (AP) — A slate of six Nevada Republicans have again been charged with submitting a bogus c

U.S. passport demand continues to overwhelm State Department as frustrated summer travelers demand answers

Washington — Connie Raynor and Vicki Heller were making their packing lists for the European cruise

Selena Gomez Praises “Special” Francia Raísa Amid Feud Rumors

Selena Gomez loves her pal Francia Raísa like a love song, baby. The singer proved she's still close